Bionexus Gene LabBGLC
13F holders, Q1 2024 (March 31)4holders
$0.70avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Bionexus Gene Lab Corp. (BGLC) in their 13F filings. The largest holders were Virtu Financial LLC ($33K), Geode Capital Management, LLC ($17K) and HRT Financial LP ($15K).
- Company
- Bionexus Gene Lab Corp.
- CUSIP
- 090628207
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $21K |
| Exits | 3 | $29K |
Ownership 4 holders
| Virtu Financial LLC | 0.00% | Add +79.9% | 47,037 | $33K |
| Geode Capital Management, LLC | 0.00% | No change | 23,681 | $17K |
| HRT Financial LP | 0.00% | New | 21,903 | $15K |
| UBS Group AG | 0.00% | New | 8,418 | $6K |
"% of holder's portfolio" is BGLC's weight in each manager's 13F, not the share of Bionexus Gene Lab Corp. the manager owns.